Key Highlights
- 29.62% is the one-week decline for Backblaze (NASDAQ:BLZE) to USD 9.22, per published market data (October 16, 2026 intraday). The stock fell 22.2% on October 14 alone, from USD 12.51 to USD 9.73 (own arithmetic), and the RSI is 23.5.
- 19.71% is the one-week decline for ManpowerGroup (NYSE:MAN) to USD 43.29, with an RSI of 21.9. The October 15, 2026 report showed adjusted EPS of USD 1.01, in line, but fourth quarter EPS guidance with a USD 1.08 midpoint below the USD 1.10 consensus.
- 14.11% is the one-week decline for Target Hospitality (NASDAQ:TH) to USD 15.70, with an RSI of 30.0. The stock fell 7.18% on October 15 to USD 16.02, while TDR Capital entities have sold 40.05 million shares in 2026 (own arithmetic).
- 9.9% is the one-week decline for Candel Therapeutics (NASDAQ:CADL) to USD 8.73 from USD 10.00 on October 12, with an RSI of 28.8. The company plans a Biologics License Application in the fourth quarter of 2026.
Backblaze (NASDAQ:BLZE)
The largest drop of the week has the thinnest explanation. No company-specific catalyst was identified in the filings and releases reviewed through October 16, 2026. The stock had risen 7.4 times from its USD 3.26 low to its USD 23.99 high (own arithmetic), and at USD 9.22 it is 61.6% below that high. What separates it from the other three is volume: 455,048 shares changed hands by 11:11 a.m. ET on October 16 against a 2.09 million average, so the latest session was thin, and the damage came earlier in the week. At USD 9.22 the 455,048 shares equal USD 4.2 million of turnover (own arithmetic). The price is 38.0% below the 50-day average of USD 14.88 (own arithmetic). Short interest is 11.65% of float, up 25.45% month over month, and USD 175 million of convertible notes convert at USD 21.94. The best-supported explanation is a positioning unwind, labelled as inference. So what: revenue growth of 13.9% and 2026 guidance of USD 172 million to USD 174 million sit against a net loss of USD 20.43 million. Results are due November 2, 2026. Beta is 1.56, so market moves are amplified, and analysts hold 8 Buy, 1 Hold and 1 Sell ratings with a USD 19.71 average target, per published market data.
ManpowerGroup (NYSE:MAN)
This drop has a clear cause: a guidance midpoint below consensus. ManpowerGroup reported on October 15, 2026 that third quarter revenue was USD 4.84 billion against USD 4.85 billion expected, and gross margin was 15.9% against 16.6% a year earlier. The shares traded down 14.9% intraday that day, and the weekly decline of 19.71% extends it. What separates it from the other three is that analysts responded with numbers: Goldman Sachs cut its target to USD 50 from USD 57, JPMorgan to USD 50 from USD 59, UBS to USD 48 from USD 56 and Baird to USD 65 from USD 72. The 52-week range is USD 25.15 to USD 63.88, so the price is 32.2% below the high (own arithmetic). Net debt was USD 870 million, up from USD 806 million (own arithmetic). The annual dividend of USD 1.44 yields 3.3%. So what: Becky Frankiewicz takes over as chief executive on January 1, 2027, and the USD 200 million savings target by 2028 must offset thinner margins. Fourth quarter results have no announced date. Cash fell to USD 233.1 million from USD 871.0 million at December 31, 2025, while debt fell to USD 1,103 million from USD 1,677 million.
Target Hospitality (NASDAQ:TH)
Supply, not earnings, is the best-supported explanation. TDR Capital entities Arrow Holdings and MFA Global sold 8.05 million shares at USD 14.00 in April, 7.0 million at USD 17.00 on May 28, 14.0 million at USD 18.50 on September 8, and filed notices for 11.0 million more on October 1, followed by a 7.6% fall on October 2. No company-specific catalyst was identified for the October 15 decline. What separates it from the other three is operating strength: second quarter revenue rose 39% to USD 85.5 million and 2026 revenue guidance was raised to USD 410 million to USD 420 million. Capital spending of USD 490 million to USD 510 million against EBITDA guidance of USD 85 million to USD 95 million leaves a USD 410 million gap at midpoints (own arithmetic), funded by a USD 660 million revolver. So what: net leverage of 0.6 times at June 30 will rise. The sellers' remaining holdings were not disclosed, and results are estimated for November 5, 2026.
Candel Therapeutics (NASDAQ:CADL)
The smallest decline of the four sits in front of the largest binary event. Candel plans to submit a Biologics License Application for aglatimagene besadenovec in prostate cancer in the fourth quarter of 2026, citing a 39% improvement in disease-free survival against placebo. No company-specific catalyst for the weekly decline was identified; Zacks Research cut its rating to strong sell on October 14. What separates it from the other three is cash cover: USD 201.6 million at June 30, 2026 equals 30.2% of the USD 668 million market capitalization (own arithmetic), and the company estimates funding into the first quarter of 2028. The price is 4.4% below the 200-day average of USD 9.32 and 37.6% below the USD 14.00 high (own arithmetic). A CTO sold 7,000 shares at USD 12.00 on August 17. So what: filing timing can slip, and a launch would raise burn. Third quarter results are estimated for November 12, 2026. Second quarter operating costs of USD 26.7 million imply 22.7 months of runway (own arithmetic).
Where Things Stand
Backblaze fell hardest at 29.62%, ahead of ManpowerGroup at 19.71%, Target Hospitality at 14.11% and Candel at 9.9%, per published market data. The ranking by documented cause runs the other way. ManpowerGroup (NYSE:MAN) has a dated earnings event, and Target Hospitality has a pattern of sponsor sales. Backblaze (NASDAQ:BLZE) has no identified company-specific catalyst. Candel has none either, and it carries a Biologics License Application filing plan for the fourth quarter. Both Target Hospitality and Candel carry financing questions. A decline without a cause can reverse or extend, and RSI is not a forecast. Next dated events: Backblaze on November 2, Target Hospitality on November 5 and Candel on November 12, 2026, the last two estimated.






Please wait processing your request...